A case of acute promyelocytic leukemia variant with derivative chromosome 3 der(3)t(3;8) associated with 8q partial gain
暂无分享,去创建一个
P. Musto | Stefania Trino | L. De Luca | F. D’Auria | L. Possidente | F. Nozza | Gabriella Vona | F. La Rocca | V. Grieco | Filomena Nozza | Vitina Grieco
[1] F. Lo‐Coco,et al. Molecular remission as a therapeutic objective in acute promyelocytic leukemia , 2018, Leukemia.
[2] C. Tirado,et al. A t(3;8)(q26.2;q24) involving the EVI1 (MECOM) Gene. , 2018, Journal of the Association of Genetic Technologists.
[3] P. Pandolfi,et al. Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure. , 2017, Cancer cell.
[4] R. Das,et al. Isolated Central Nervous System (CNS) Relapse in Paediatric Acute Promyelocytic Leukaemia: A Systematic Review. , 2017, Journal of clinical and diagnostic research : JCDR.
[5] Mario Cazzola,et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.
[6] F. Lo‐Coco,et al. Current management of newly diagnosed acute promyelocytic leukemia. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] T. Yamane,et al. Therapy-related myelodysplastic syndrome: a case study. , 2015, American journal of blood research.
[8] T. Haferlach,et al. AML with gain of chromosome 8 as the sole chromosomal abnormality (+8sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patients. , 2015, Leukemia research.
[9] D. Douer,et al. Extramedullary disease in APL: a real phenomenon to contend with or not? , 2014, Best practice & research. Clinical haematology.
[10] S. Lowe,et al. Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia , 2010, The Journal of experimental medicine.
[11] R. Hills,et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. , 2010, Blood.
[12] Holly M Knoderer,et al. Central nervous system involvement at the time of presentation in acute promyelocytic leukemia , 2010, Pediatric blood & cancer.
[13] V. Cóser,et al. External auditory canal and middle ear relapse of acute promyelocytic leukemia treated with arsenic trioxide: case report and review of the literature. , 2010, Journal of pediatric hematology/oncology.
[14] G. Terzoudi,et al. Isochromosome der(17)(q10)t(15;17) in Acute Promyelocytic Leukemia Resulting in an Additional Copy of the RARA-PML Fusion Gene: Report of 4 Cases and Review of the Literature , 2010, Acta Haematologica.
[15] M. Tormo,et al. Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy , 2010, Haematologica.
[16] C. Bloomfield,et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.
[17] Z. Estrov,et al. Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience , 2009, International journal of hematology.
[18] H. Dombret,et al. Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy , 2006, Leukemia.
[19] R. Gershoni-baruch,et al. Derivative (7)t(7;8)(q34;q21): an additional chromosome aberration in acute promyelocytic leukemia-prognostic influence debated. , 2004, Cancer genetics and cytogenetics.
[20] Keun-Wook Lee,et al. Extramedullary Relapse Confirmed by Fluorescence In Situ Hybridization Study of an Ear Mass in Acute Promyelocytic Leukemia , 2004, International journal of hematology.
[21] F. Mandelli,et al. Early detection of meningeal localization in acute promyelocytic leukaemia patients with high presenting leucocyte count , 2003, British journal of haematology.
[22] J. Vial,et al. Derivative (7)t(7;8)(q34;q21). a new additional cytogenetic abnormality in acute promyelocytic leukemia. , 2003, Cancer genetics and cytogenetics.
[23] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[24] G. Specchia,et al. Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated ‘sanctuary’? , 2002, Leukemia.
[25] M. L. Le Beau,et al. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia. , 2002, Blood.
[26] M. Vignetti,et al. Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] G. Ooi,et al. Unusual sites of involvement by hematologic malignancies. Case 3. External auditory canal tumor: a rare chloroma in acute promyelocytic leukemia with a complete response to arsenic trioxide. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] J. Cervera,et al. Cutaneous promyelocytic sarcoma at sites of vascular access and marrow aspiration. A characteristic localization of chloromas in acute promyelocytic leukemia? , 2000, Haematologica.
[29] Y. Yuan,et al. A rare variant translocation t(3;8)(q29;q22) without AML1/ETO fusion transcript in a case of oligoblastic leukemia. , 1998, Leukemia research.
[30] A. Biondi,et al. Extramedullary involvement in patients with acute promyelocytic leukemia , 1998, Cancer.
[31] R. Ohno,et al. Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid. , 1997, Internal medicine.